top of page


In The Future.

Trenchant Technologies Capital.jpg

About Trenchant Technologies Capital 

Trenchant Technologies Capital is a gateway to exciting private investment opportunities not typically available to retail investors. Based on our team’s significant experience in incubating and capitalizing companies to public listing exits, we've engineered a secure pathway for you to participate in exclusive private equity opportunities alongside seasoned investors, unlocking the potential to share in impressive returns while fuelling the expansion of promising high-growth companies.
Our focus is on the intersection of novel technologies including Artificial Intelligence and Quantum Computing and traditional businesses primarily in the medical, biomedical and technologies sectors. We believe novel and evolving technologies have the ability to create disruptive businesses that can generate significant growth and out-compete nascent businesses. Our team undergoes a rigorous due diligence process to identify solid, financially sound companies led by seasoned management teams that are strong candidates for acquisition or an initial public offering (IPO).

Our Latest Investment: GNQ Insilico

GNQ Insilico is a health tech company that is addressing the most critical pain points faced by the life sciences industry on the road to drug development: rising costs and increasing time required to bring the average drug to market. Traditional methods of conducting clinical trials may not be sustainable as high rates of failure exceed revenues from new drugs. By combining AI-driven insights with domain expertise and a commitment to data privacy and ethical considerations, GNQ Insilico's technology platform can accelerate research processes, enhance genomic insights, and contribute to advancements in precision medicine and healthcare.

In May 2024, Trenchant Technologies Capital acquired a 20% ownership interest in GNQ Insilico from parent company My Next Health Inc. Further, Trenchant holds an option to acquire up to 40% of GNQ Insilico. Read more here. 

Why Invest in Trenchant Technologies Capital?

Exciting Deal Flow
Trenchant Technologies Capital offers investors the opportunity to participate in early-stage private equity deal flow through a secure public market investment structure. We focus on businesses leveraging novel technologies because we believe novel and evolving technologies have the ability to create disruptive businesses that can generate significant growth.
Strong Management
Trenchant Technologies Capital is managed by a team of seasoned executives with a combined 50 years of senior management experience in structuring and financing public company listings. 
Trenchant’s early-stage investments are underpinned by our team's management of the listing of our investments shares, providing shareholders with capital appreciation through the recycling of invested capital.
Stock Market Graph
bottom of page